CXCR4 and integrin might synergistically promote lymphatic metastasis in lung cancer, and act as clinical predictors of lymph node metastasis in non-SCLC [29, 30]. The gene discussed is CXCR4; the disease is metastatic malignant neoplasm in the lymph nodes.